Skip to content

A Study on Motor Function in Subjective Cognitive Decline Based on a Functional Near-Infrared Spectroscopy Dual-Task Paradigm and Non-Pharmacological Intervention

A Study on Motor Function in Subjective Cognitive Decline Based on a Functional Near-Infrared Spectroscopy Dual-Task Paradigm and Non-Pharmacological Intervention

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600127639
Enrollment
Unknown
Registered
2026-07-03
Start date
2026-01-10
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subjective Cognitive Decline

Interventions

Mild Cognitive Impairment (MCI) Group:Physical exercise and Mediterranean diet
Healthy Control (HC) Group:Physical exercise and Mediterranean diet
Subjective Cognitive Decline (SCD) Group:Physical exercise and Mediterranean diet

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Aged 60 years or older; 2.Presence of persistent self-perceived memory decline within the past 5 years; 3.Normal Activities of Daily Living (ADL); 4.A score of >5 on the SCD-Q9 questionnaire; 5.Normal performance on standardized neuropsychological tests; 6.Absence of severe head motion artifacts, scalp infections, or other factors that could interfere with optical signal acquisition; 7.Not concurrently participating in other clinical drug trials; 8.Provision of written informed consent, demonstrating voluntary participation and commitment to complete the follow-up assessments.

Exclusion criteria

Exclusion criteria: 1.History of neurological disorders (e.g., stroke, traumatic brain injury, Parkinson's disease, epilepsy); 2.Psychiatric conditions (e.g., depression, anxiety) responsible for pseudo-cognitive complaints; 3.Significant systemic illnesses (e.g., severe cardiac, hepatic, or renal failure, thyroid dysfunction, vitamin B12 deficiency); 4.History of drug or alcohol dependence; 5.Long-term use of medications that significantly impact cognitive function; 6.Inability to walk independently;

Design outcomes

Primary

MeasureTime frame
Behavioral Measures;Functional Connectivity (FC);Cerebral Hemodynamics;

Secondary

MeasureTime frame
Neuropsychological assessment;

Countries

China

Contacts

Public ContactHu Yuting

The Affiliated Hospital of Xuzhou Medical University

xz_hyt@163.com+86 516 85622022

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026